These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 37498232)

  • 21. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug permeation through biomembranes: cyclodextrins and the unstirred water layer.
    Loftsson T
    Pharmazie; 2012 May; 67(5):363-70. PubMed ID: 22764564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-Dependent Solubility-Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions.
    Sugita K; Takata N; Yonemochi E
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33801447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Solubility Improvement via Formation of an Amorphous Composite of Indomethacin and Sulindac on Membrane Permeability.
    Hatanaka Y; Uchiyama H; Furukawa S; Takase M; Yamanaka S; Kadota K; Tozuka Y
    Chem Pharm Bull (Tokyo); 2023; 71(3):257-261. PubMed ID: 36858532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro-in vivo correlation in the effect of cyclodextrin on oral absorption of poorly soluble drugs.
    Aihara R; Messerschmid R; Mizoguchi M; Wada K; Minami K; Higashino H; Takagi T; Kataoka M; Yamashita S
    Int J Pharm; 2021 May; 600():120494. PubMed ID: 33744446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.
    Fine-Shamir N; Beig A; Zur M; Lindley D; Miller JM; Dahan A
    Mol Pharm; 2017 Jun; 14(6):2138-2146. PubMed ID: 28505451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of food effect by bile micelles on oral drug absorption considering free fraction in intestinal fluid.
    Sugano K; Kataoka M; Mathews Cda C; Yamashita S
    Eur J Pharm Sci; 2010 May; 40(2):118-24. PubMed ID: 20307655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methacrylate-Copolymer Eudragit EPO as a Solubility-Enabling Excipient for Anionic Drugs: Investigation of Drug Solubility, Intestinal Permeability, and Their Interplay.
    Fine-Shamir N; Dahan A
    Mol Pharm; 2019 Jul; 16(7):2884-2891. PubMed ID: 31120762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of Experimental Approach for Development of Rapid High Performance Liquid Chromatographic Process for Simultaneous Estimation of Metoprolol, Telmisartan, and Amlodipine from Formulation: Greenness and Whiteness Evaluation.
    Attimarad M; Alali MJ; Alali HA; Alabdulmuhsin DH; Alnajdi AK; Venugopala KN; Nair AB
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation and optimization of spray-dried amlodipine solid dispersion for enhanced oral absorption.
    Jang DJ; Sim T; Oh E
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1133-41. PubMed ID: 23009032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the Formation Mechanism of Coamorphous Andrographolide-Oxymatrine Based on Molecular Dynamics and Spectroscopy.
    Fang X; Hu Y; Huang Z; Han L; Li B; Lu S; Cao Y
    J Pharm Sci; 2022 Jul; 111(7):2056-2071. PubMed ID: 35167885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the p
    Hu Y; Guo Y; Li B; Xu R; Fang X; Cao Y; Liu Z; Jiang C; Lu S
    ACS Omega; 2021 Feb; 6(4):3106-3119. PubMed ID: 33553927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coamorphous atorvastatin calcium to improve its physicochemical and pharmacokinetic properties.
    Shayanfar A; Ghavimi H; Hamishekar H; Jouyban A
    J Pharm Pharm Sci; 2013; 16(4):577-87. PubMed ID: 24210065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous determination of hydrochlorothiazide, amlodipine, and telmisartan with spectrophotometric and HPLC green chemistry applications.
    Tiris G; Mehmandoust M; Lotfy HM; Erk N; Joo SW; Dragoi EN; Vasseghian Y
    Chemosphere; 2022 Sep; 303(Pt 3):135074. PubMed ID: 35667505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicity.
    Katneni K; Charman SA; Porter CJ
    J Pharm Pharmacol; 2008 Oct; 60(10):1311-9. PubMed ID: 18812024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of γ-cyclodextrin effect on permeation of lipophilic drugs: application of cellophane/fused octanol membrane.
    Muankaew C; Jansook P; Loftsson T
    Pharm Dev Technol; 2017 Jun; 22(4):562-570. PubMed ID: 27146583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations.
    Beig A; Agbaria R; Dahan A
    PLoS One; 2013; 8(7):e68237. PubMed ID: 23874557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.